This Article Accepted Manuscript (PDF) All Versions of this Article: 138/6/895    most recent REP-09-0092v1 Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burton, G. J Articles by Jauniaux, E. Search for Related Content PubMed PubMed Citation Articles by Burton, G. J Articles by Jauniaux, E.

Regulation of vascular growth and function in human placenta

G Burton, Centre for Trophoblast Research and Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom
D Charnock-Jones, Centre for Trophoblast Research and Department of Obstetrics & Gynaecology, University of Cambridge, Cambridge, United Kingdom
E Jauniaux, Academic Department of Obstetrics & Gynaecology, Institute for Women's Health, UCL, London, United Kingdom

Correspondence: Graham J Burton, Email: gjb2{at}cam.ac.uk

Abstract

During the course of 9 months the human placenta develops into a highly vascular organ. Vasculogenesis starts during the third week post-conception. Haemangioblastic cell cords differentiate in situ from mesenchymal cells in the villous cores, most probably under the influence of vascular endothelial growth factor (VEGF-A) secreted by the overlying trophoblast. The cords elongate through proliferation and cell recruitment, and connect with the vasculature of the developing fetus. A feto-placental circulation starts around 8 weeks of gestation. Elongation of the capillaries outstrips that of the containing villi, leading to looping of the vessels. The obtrusion of both capillary loops and new sprouts results in the formation of terminal villi. Branching and non-branching angiogenesis therefore play key roles in villous morphogenesis throughout pregnancy. Maternal circulating levels of VEGF-A and placenta growth factor (PlGF) vary across normal pregnancy, and in complicated pregnancies. Determining the impact of these changes on placental angiogenesis is difficult, as the relationship between levels of factors in the maternal circulation and their effects on fetal vessels within the placenta remains unclear. Furthermore, the trophoblast secretes large quantities of soluble receptors capable of binding both growth factors, influencing their bioavailability. Villous endothelial cells are prone to oxidative stress, which activates the apoptotic cascade. Oxidative stress associated with onset of the maternal circulation, and with incomplete conversion of the spiral arteries in pathological pregnancies, plays an important role in sculpting the villous tree. Suppression of placental angiogenesis results in impoverished development of the placenta, leading ultimately to fetal growth restriction.

This article has been cited by other articles:

				A. T. Grazul-Bilska, P. P. Borowicz, M. L. Johnson, M. A. Minten, J. J. Bilski, R. Wroblewski, D. A. Redmer, and L. P. Reynolds Placental development during early pregnancy in sheep: vascular growth and expression of angiogenic factors in maternal placenta Reproduction, July 1, 2010; 140(1): 165 - 174. [Abstract] [Full Text] [PDF]

				C. T. Ha, J. A. Wu, S. Irmak, F. A. Lisboa, A. M. Dizon, J. W. Warren, S. Ergun, and G. S. Dveksler Human Pregnancy Specific Beta-1-Glycoprotein 1 (PSG1) Has a Potential Role in Placental Vascular Morphogenesis Biol Reprod, July 1, 2010; 83(1): 27 - 35. [Abstract] [Full Text] [PDF]

				H N Jabbour Vascular function in female reproduction Reproduction, December 1, 2009; 138(6): 867 - 868. [Full Text] [PDF]